
Featured
The Genetic Recalibration of Human Longevity: How In Vivo Base Editing is Rewriting Cardiovascular and Sports Medicine
The successful Phase 3 completion of in vivo base-editing therapy for Lp(a) reduction marks a permanent shift from chronic cardiovascular management t...
Read Full Story →

